Hi Jase
Gene editing is certainly not my field.
I was wondering what the FDA's response would be to a 'crafted' trial that only accepted patients showing a higher level of T cell diversity.
The response rate could be phenomenal ... and lead to a very fast approval. Of course, I could be dreaming too.
Just my musings.
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-49
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $312.4M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.3¢ | 4.1¢ | $672.3K | 16.04M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 4003556 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 197261 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |